As the leader in advanced imaging for neurovascular conditions, RapidAI seeks to continue developing its platform for other vascular conditions that will offer hospitals greater capability and opportunity to improve patient outcomes.
Prior to working with Kuno, RapidAI, then known only as Rapid, didn’t do much in the way of marketing. They knew the needed to both remain competitive in their industry and to raise awareness about their product offerings. The Vice President of Marketing knew HubSpot was the platform she wanted to use. RapidAI selected Kuno as their HubSpot agency based on Kuno’s demonstrated knowledge and expertise in the healthcare space.
Rapid wanted to be a competitive driver in their industry and remain at the forefront of stroke technology. Their website was migrated to HubSpot, and Kuno assisted with HubSpot Marketing onboarding. This enabled tracking for all efforts to be centrally located, and enabled the newly rebranded RapidAI to have a robust Zoom integration for webinars. The rebrand had a specific intent: to showcase how artificial intelligence could assist in clinical decision making and reduce time to treatment.
Expertise in rebranding, user experience and website strategy were at the fore of the initial relationship. Kuno also implemented a strong SEO strategy that led to numerous No. 1 keyword rankings.
When Rapid.ai completed its clinical trials and was ready to go to market, the company had little marketing collateral and minimal web presence. To stay competitive, the company partnered with Kuno to improve their website and develop marketing material. Through the process, it was determined that it would be best to change the name from Rapid.ai to RapidAI, and Kuno would redesign the website, logo and branding guidelines to support the rebrand.
The main goal was to educate the market on RapidAI’s products and services and gain brand awareness as a leader in the medical technology space. These elements are essential to drive conversions and demo requests.
RapidAI is now used in over 2,000 hospitals worldwide. It is approved for use in over 100 countries and has been tested in 14 clinical trials around the world.
Additionally, the company recently secured a $75 million Series C growth investment.
Kuno helped to drive digital awareness through increased Google rankings, website traffic, contact conversions and time on page.
Increased 1373% six months after website launch
Increased 177% six months after website launch
Increased 147% six months after website launch
Moved to number 1 spot for “stroke software”
377% improvement in Top 10 rankings
“We have been working with Kuno Creative for over two years. Kuno spearheaded our HubSpot integration, created a new brand identity for our company and designed and built a new website for us on the HubSpot CMS. Their work is creative and fresh. Their team is smart, thinks outside the box and a pleasure to work with.”
In the beginning, the messaging was solely for the acute stroke care audience. As new product lines were developed, messaging broadened to feature aneurysm, a chronic neuro condition, and pulmonary embolism, which speaks to a separate audience. Each change requires a concerted effort to ensure messaging is cohesive, yet effectively addresses the distinctions among the audiences.
Kuno continues to provide its expertise as RapidAI continues to grow, offering strategic recommendations as the medical technology company navigates adding new service areas and increasing market share.